Surgery Partners, Inc.
Company Stats
- Market Cap
- $1.8B
- as of Sep 30, 2026
- Shares Outstanding
- 130.9M
- Free Float
- 83.6%
Income Statement
- Revenue
- $3.3B
- Operating Income
- $389.5M
- Net Income
- -$77.9M
- EBITDA
- $565.5M
- Revenue Growth, 3Y
- 9.2%
- FCF Margin, 3Y Avg
- 6.7%
- FCF Margin, Worst Year
- 5.9%
Cash Flow
- Free Cash Flow
- $195.6M
- FCF Yield
- 10.8%
- Owner FCF Yield
- 10.0%
Balance Sheet
- Cash & Equivalents
- $239.9M
Returns & Capital
- SBC, 3Y Avg
- $21.9M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $3.3B | $195.6M | 5.9% |
| FY2024 | $3.1B | $209.7M | 6.7% |
| FY2023 | $2.7B | $205.0M | 7.5% |
| FY2022 | $2.5B | $78.2M | 3.1% |
| FY2021 | $2.2B | $29.5M | 1.3% |
Annual filing data through FY ended December 31, 2025; shares and float as of November 2, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Earnings
Other Coverage
November 9, 2026
Deals
HealthSpan Partners to Buy Surgery Partners in $6.0 Billion Cash Deal
September 28, 2026
QBook
Stronger demand supports expansion as pricing diverges
August 14, 2026
Industry Earnings Roundup
Healthcare Earnings: Demand Surges, Costs Bite Back
July 24, 2026
Deals
Surgery Partners to Sell Hospital Interests in $795 Million Cash Deal
HealthSpan Partners to Buy Surgery Partners in $6.0 Billion Cash Deal
September 28, 2026
QBook
Stronger demand supports expansion as pricing diverges
August 14, 2026
Industry Earnings Roundup
Healthcare Earnings: Demand Surges, Costs Bite Back
July 24, 2026
Deals
Surgery Partners to Sell Hospital Interests in $795 Million Cash Deal